Assessment of the cost burden of episodic recurrent vestibular vertigo in the US SS Jeong, KN Simpson, JM Johnson, HG Rizk JAMA Otolaryngology–Head & Neck Surgery 148 (12), 1103-1110, 2022 | 9 | 2022 |
Patient Perceptions of Audio-Only Versus Video Telehealth Visits: A Qualitative Study Among Patients in an Academic Medical Center Setting R Kruis, EA Brown, J Johnson, KN Simpson, J McElligott, J Harvey Telemedicine Reports 5 (1), 89-98, 2024 | 6 | 2024 |
Interprofessional staff perspectives on the adoption of or black box technology and simulations to improve patient safety: a multi-methods survey K Campbell, A Gardner, DJ Scott, J Johnson, J Harvey, A Kazley Advances in Simulation 8 (1), 24, 2023 | 5 | 2023 |
Are There Racial Disparities in Perioperative Pain? A Retrospective Study of a Gynecological Surgery Cohort AC Kahveci, MJ Dooley, J Johnson, AR Mund Journal of PeriAnesthesia Nursing 39 (1), 82-86, 2024 | 1 | 2024 |
PAYMENT POLICY IMPACT ON HOME HEALTH ACCESS FOR PEOPLE LIVING WITH DEMENTIA S Knox, D Brinton, J Johnson, K Simpson Innovation in Aging 8 (Suppl 1), 25, 2024 | | 2024 |
Mapping healthcare utilization of people with Alzheimer’s Disease and Related Dementias to identify priority areas in the State of South Carolina S Knox, M Dooley, J Johnson, K Simpson Alzheimer's & Dementia 20, e093244, 2024 | | 2024 |
Differences in Patient Characteristics at Home Health Admission for Medicare Beneficiaries with and without Dementia. S Knox, J Johnson, M Dooley, K Simpson 2024 Annual Research Meeting, 2024 | | 2024 |
Translating Value Across Telehealth Stakeholders: A Rapid Review of Telehealth Measurement Evidence and a New Policy Framework to Guide Telehealth Researchers K Wiley Jr, J Johnson, C Coleman, C Olson, J Chuo, D McSwain Telemedicine and e-Health, 2024 | | 2024 |
EE61 Cost Effectiveness of Treating Ivig-Resistant Kawasaki Disease Children with Second Round IVIG Versus Infliximab J Johnson, D Brinton, K Simpson, J Burns, A Simpson Value in Health 26 (6), S70, 2023 | | 2023 |
Characteristics of Children and Adults with Sickle Cell Disease: Patterns of Utilization and Cost By Quarter (2017-2020) J Johnson, D Williams, J Harvey 2022 Annual Research Meeting, 2022 | | 2022 |
Cost-Effectiveness Analysis of Second Intravenous Immunoglobulin Infusion Versus Infliximab for Treating Ivig-Resistant Kawasaki Disease Patients J Johnson, KN Simpson, A Simpson, A Tremoulet, J Burns Available at SSRN 4796859, 0 | | |